OncoRes Raises $27m for Breast Cancer Tool

Monday, 16 February 2026 / Sam Jones / Business News 

Source: Image courtesy of OncoRes Medical

Excerpt from article:

The WA company behind an imaging device which can reduce the number of repeat surgeries for breast cancer patients has received $27 million in a private funding round to support its push to US FDA approval.

Based in Perth, OncoRes Medical has developed a handheld device, called a quantitative micro-elastography (QME) imaging system, to assist surgeons in accurately identifying and removing cancerous tissue, named Elora.

Granted FDA breakthrough device designation in 2020, a label which grants expedited approvals and tax incentives for FDA approval, the company opened Australian clinical trials across six hospitals in two states recently.

This article was first published by Business News. Click here for full article.